Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Cancer
        Illuminating cancer research: what tumor burden alone can’t tell you.
            April 3, 2024 -
            3 min read
          
          
         
      Disease Research
        Molecular imaging is helping to reduce post-surgical infections.
            April 3, 2024 -
            3 min read
          
          
         
       
      Metabolic research, Drug Development
        In vivo imaging study highlights potential for non-invasive evaluation of NASH.
            April 3, 2024 -
            2 min read
          
          
         
      Disease Research, Infectious Disease Research
        The important role in vivo bioluminescence imaging plays in COVID-19 research.
            April 3, 2024 -
            1 min read
          
          
         
      Small Molecule Drug Discovery
        Radioligand binding assays: from opiate receptors to drug discovery mainstay.
            April 3, 2024 -
            2 min read
          
          
         
      Neuroscience Research
        Optical imaging facilitates key neurological disease research.
            April 3, 2024 -
            2 min read
          
          
         
      Neuroscience Research
        Radiolabeled α-Bungarotoxin sheds light on role of neuronal nicotinic acetylcholine receptors.
            April 3, 2024 -
            3 min read
          
          
         
      Small Molecule Drug Discovery
        How CRISPR can identify regulators of Alzheimer’s-related protein tau?
            March 31, 2024 -
            4 min read
          
          
         
      Small Molecule Drug Discovery
        How to choose the right plate reader?
            March 27, 2024 -
            1 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  